fda warning letters compounded tirzepatide 2024 2025 Issues Warnings Against Illegal GLP-1 Marketing Tirzepatide, FDA, and Compounding: Understanding
Description
Hemmingway (Eli Lilly and Company) for medical writing and editorial support
Rosie G
If you can access one medication for 3 months but then need to switch to the other due to cost or availability, having a safe transition protocol makes the alternating inevitable rather than optional
Most patients begin at 2.5 mg once a week, which gives your body time to adjust before the dose steps up based on your response and tolerance
Focus on your health goals while we manage the paperwork, ensuring you can access the treatment you need with ease
